Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Statement re Offer for Subscription

28 Jan 2025 12:15

RNS Number : 9887U
Maven Income & Growth VCT PLC
28 January 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Joint Announcement by Maven Income and Growth VCT PLC, Maven Income and Growth VCT 3 PLC, Maven Income and Growth VCT 4 PLC and Maven Income and Growth VCT 5 PLC (each a VCT and together the Maven VCTs)

 

Offer for Subscription

 

28 January 2025

 

On 27 September 2024, the Maven VCTs announced the publication of a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to an offer for subscription of new Ordinary Shares of 10p each (the "Offer").

 

The Boards of the Maven VCTs are pleased to advise that, with valid subscriptions received to date under the Offer now approaching their aggregate initial fundraising target of £20 million, and in view of continued interest from potential investors, the Directors of each VCT have resolved to make use of their respective over-allotment facilities of up to £5m per VCT, as provided for under the terms and conditions of the Offer, to the extent required to meet any additional demand.

 

The deadline for receipt of applications for the Offer is 9.00 am on 4 April 2025 in relation to the tax year 2024/25 and 5.00 pm on 25 April 2025 in relation to the tax year 2025/26. The Offer will close on 1 May 2025 unless it is fully subscribed by an earlier date or extended by the Board to no later than 26 September 2025. The deadline for the receipt of applications that will qualify for the Early Investment Incentive is 5.00 pm on 7 February 2025

 

Downloadable versions of the Prospectus documents are available at: mavencp.com/vctoffer.

 

Any enquiries in respect of the Offer, or requests for copies of the Prospectus documents (available free of charge), should be directed to:

 

Maven Capital Partners UK LLP

Kintyre House

205 West George Street

Glasgow

G2 2LW

 

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com   

Maven Capital Partners UK LLPSecretary

The information contained within this announcement is deemed by the Companies to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRLVLFLEFLFBBZ
Date   Source Headline
10th Sep 20219:57 amRNSDirector/PDMR Shareholding
10th Sep 20219:31 amRNSIssue of Equity
7th Sep 20213:09 pmRNSStatement re Dividend Investment Scheme
10th Aug 20214:31 pmRNSHalf-year Report
5th Aug 20219:17 amRNSStatement re NAV and Interim Dividend
7th May 20213:54 pmRNSTransaction in Own Shares
7th May 20212:06 pmRNSDirector/PDMR Shareholding
7th May 20212:06 pmRNSDirector/PDMR Shareholding
7th May 20212:03 pmRNSIssue of Equity
5th May 202112:56 pmRNSTransaction in Own Shares
4th May 20214:01 pmRNSStatement re Dividend Investment Scheme
4th May 20213:54 pmRNSDirector/PDMR Shareholding
4th May 20213:25 pmRNSIssue of Equity
27th Apr 20211:46 pmRNSNet Asset Value(s)
27th Apr 20211:17 pmRNSResult of AGM
6th Apr 20217:00 amRNSIssue of Equity
1st Apr 202110:33 amRNSStatement re Offer for Subscription
23rd Mar 20213:41 pmRNSPublication of Suppl.Prospcts
15th Mar 20213:37 pmRNSAnnual Financial Report
3rd Mar 20213:05 pmRNSHolding(s) in Company
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNSIssue of Equity
24th Feb 20214:41 pmRNSTransaction in Own Shares
16th Feb 20217:00 amRNSNet Asset Value and Proposed Final Dividend
8th Feb 20213:59 pmRNSStatement re Offer for Subscription
28th Jan 20214:40 pmRNSStatement re Offer for Subscription
30th Nov 20204:47 pmRNSTransaction in Own Shares
27th Nov 202010:45 amRNSResult of General Meeting
23rd Nov 20205:03 pmRNSTransaction in Own Shares
16th Nov 20204:49 pmRNSTransaction in Own Shares
26th Oct 20207:00 amRNSPublication of a Prospectus
16th Oct 202010:15 amRNSNet Asset Value(s)
28th Aug 202011:27 amRNSDirector/PDMR Shareholding
28th Aug 202010:31 amRNSIssue of Equity
26th Aug 20205:24 pmRNSTransaction in Own Shares
21st Aug 20204:11 pmRNSStatement re NAV and DIS
31st Jul 20207:00 amRNSHolding(s) in Company
29th Jul 20205:11 pmRNSTransaction in Own Shares
29th Jul 202010:55 amRNSHalf-year Report
22nd Jul 20202:25 pmRNSStatement re Intended Joint Offersfor Subscription
16th Jul 20202:38 pmRNSStatement re NAV and Interim Dividend
29th Jun 20202:44 pmRNSDirector Declaration
14th May 20204:47 pmRNSTransaction in Own Shares
29th Apr 20204:36 pmRNSTransaction in Own Shares
28th Apr 202012:12 pmRNSResult of AGM
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:01 pmRNSSuspension of Dividend Investment Scheme (DIS)
19th Mar 20204:30 pmRNSAGM Update – Notification of Change of Venue
11th Mar 20205:23 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.